Proliferation and Metastasis
|
|
miR-208 |
BMSCs |
Osteosarcoma cells |
PDCD4/ERK1/2 |
Increase the viability, migration, and clonogenicity of OS |
[95] |
miR-206 |
BMSCs |
Osteosarcoma cells |
TRA2B |
Promote OS cell proliferation, migration, invasion and induce cell apoptosis |
[96] |
MALAT1 |
BMSCs |
Osteosarcoma cells |
MALAT1/miR-143/NRSN2/Wnt/β-catenin |
Promote OS cell proliferation, migration, and invasion |
[52] |
PVT1 |
BMSCs |
Osteosarcoma cells |
PVT1/miR-183–5p/ERG |
Promote OS growth and metastasis |
[51] |
ATG5 |
BMSCs |
Osteosarcoma cells |
/ |
Promote OS cell proliferation, migration, and invasion |
[97] |
COLGALT2 |
ADSCs |
Osteosarcoma cells |
/ |
Promote OS cell proliferation, migration, and invasion |
[98] |
Linc00852 |
high AXL expression Osteosarcoma cells |
low AXL expression Osteosarcoma cells |
Linc00852/miR-7–5p/AXL |
Promote cell proliferation, migration and invasion |
[99] |
LCP1 |
BMSCs |
Osteosarcoma cells |
miR-135a-5p/LCP1/JAK2/STAT3 |
Induce the proliferation andmetastasis of OS cells |
[54] |
Hic-5 |
MG-63 |
MG-63 and HOS cells |
Hic-5/smad4-TCF/LEF -Wnt/β-catenin |
Promote cell proliferation and inhibit cell apoptosis |
[55] |
miR-1307 |
Osteosarcoma cells |
Osteosarcoma cells |
AGAP1 |
Promote OS cell proliferation, migration, and invasion |
[56] |
miR-15a |
Serum-derived exosome |
Osteosarcoma cells |
miR-15a/p5/GATA2/MDM2 |
Promote OS cell proliferation and invasion |
[100] |
miR-769–5p |
BMSCs |
Clinical specimens |
DUSP16/JNK/p38 MAPK |
promotes OS proliferation and metastasis |
[101] |
SHNG17 |
CAFs\NFs |
HOS cells |
miR-2861 |
promotes OS proliferation and metastasis |
[102] |
miR-143 |
/ |
Osteosarcoma cells |
/ |
Inhibit cell invasion |
[59] |
miR-675 |
Osteosarcoma cells |
hFOB1.19 |
CALN1 |
Promote cell migration and invasion |
[25] |
Rab22a-NeoF1 /PYK2 |
PYK2-positive osteosarcoma cells |
macrophages |
RhoA |
Facilitate the pre-metastatic niche formation |
[62] |
miR-1307 |
Osteosarcoma cells |
Osteosarcoma cells |
AGAP1 |
Promote cell proliferation, migration and invasion |
[62] |
LCP1 |
BMSCs |
Osteosarcoma cells |
miR-135a-5p/Nrdp1/JAK2/STAT3 |
Promotes OS proliferation and metastasis |
[54] |
LIFR-AS1 |
Macrophages |
Osteosarcoma cells |
miR-29a/NFIA |
Promote cell proliferation, invasion, and restrain cell apoptosis |
[103] |
|
Angiogenesis
|
|
miR-25–3p |
/ |
Osteosarcoma cells |
DKK3 |
promoted capillary formation and the invasion of vascular endothelial cells |
[42] |
EWSAT1 |
/ |
Osteosarcoma cells |
/ |
increase in sensitivity/ reactivity of vascular endothelial cells |
[104] |
OIP5-AS1 |
Osteosarcoma cells |
Osteosarcoma cells |
miR-153/ATG5 |
Increase in the angiogenesis level |
[66] |
miR-199a-5p |
Osteosarcoma cells |
HUVECs |
VEGFA |
Inhibiting the growth and angiogenesis of osteosarcoma |
[105] |
miR-148a-3p and miR-21–5p |
Osteosarcoma cells |
Raw264.7 and Huvec cells |
/ |
Influence osteoclastogenesis, bone resorption and tumor angiogenesis |
[69] |
|
Immunosuppressive
|
|
miR-148a-3p and miR-21–5p |
Osteosarcoma cells |
Raw264.7 and Huvec cells |
/ |
Influence osteoclastogenesis, bone resorption and tumor angiogenesis |
[69] |
Tim-3 |
MG63 |
Macrophages |
/ |
Induce M2 type differentiation of macrophages |
[106] |